IWM
VKTX icon

IHT Wealth Management’s Viking Therapeutics VKTX Stock Holding History

IHT Wealth Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,028
Closed -$421K – 1263
2025
Q3 		$421K Buy
16,028
+500
+3% +$14.9K 0.01% 801
2025
Q2 		$412K Buy
15,528
+777
+5% +$20.5K 0.01% 768
2025
Q1 		$356K Buy
14,751
+2,707
+22% +$85.6K 0.01% 793
2024
Q4 		$485K Sell
12,044
-1,304
-10% -$74.4K 0.02% 694
2024
Q3 		$845K Buy
+13,348
New +$783K 0.02% 548
2021
Q4 		– Sell
-12,000
Closed -$75K – 856
2021
Q3 		$75K Buy
12,000
+1,000
+9% +$6.18K 0.01% 782
2021
Q2 		$66K Sell
11,000
-2,200
-17% -$13.1K ﹤0.01% 919
2021
Q1 		$83K Sell
13,200
-10,025
-43% -$70.5K 0.01% 808
2020
Q4 		$131K Hold
23,225
– – 0.01% 709
2020
Q3 		$135K Hold
23,225
– – 0.01% 619
2020
Q2 		$167K Hold
23,225
– – 0.02% 537
2020
Q1 		$109K Hold
23,225
– – 0.02% 506
2019
Q4 		$186K Hold
23,225
– – 0.02% 574
2019
Q3 		$160K Hold
23,225
– – 0.02% 562
2019
Q2 		$193K Hold
23,225
– – 0.03% 500
2019
Q1 		$231K Sell
23,225
-100
-0.4% -$837 0.04% 424
2018
Q4 		$178K Buy
23,325
+6,100
+35% +$72.9K 0.03% 436
2018
Q3 		$300K Buy
17,225
+2,500
+17% +$29.8K 0.06% 324
2018
Q2 		$140K Buy
14,725
+3,000
+26% +$20K 0.04% 393
2018
Q1 		$51K Hold
11,725
– – 0.01% 672
2017
Q4 		$60K Buy
+11,725
New +$34.1K 0.02% 643

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IHT Wealth Management's VKTX Position: Q4 2025 in Review

IHT Wealth Management sold out of Viking Therapeutics (VKTX) in Q4 2025, closing a stake of 16,028 shares — an estimated $421K sold.

IHT Wealth Management first reported a position in VKTX in Q4 2017 and held it in 21 quarters. The position peaked at $845K in Q3 2024. 424 funds tracked by Wall St. Rank hold VKTX as of Q4 2025.

  • IHT Wealth Management reported no remaining Viking Therapeutics position as of Q4 2025 after selling out during the quarter.
  • IHT Wealth Management sold 16,028 Viking Therapeutics shares in Q4 2025, an estimated $421K.
  • IHT Wealth Management first reported a position in Viking Therapeutics in Q4 2017 and held it in 21 quarters.
  • IHT Wealth Management's Viking Therapeutics position peaked at $845K in Q3 2024.
  • 424 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2025.

Based on IHT Wealth Management's 13F filing for Q4 2025, filed 17 Feb 2026.